Precision cancer treatment is effective in treating tumors
Summary: Researchers at Children’s Hospital Los Angeles have just completed a precision cancer trial. They found that three of four cancer patients, both adult and child, responded well to the new precision therapy targeting a specific gene mutation. This article was originally published on LongevityFacts. Brady Hartman is the author.
Children’s Hospital Los Angeles reports that three-fourths (74%) of adults and kids with advanced cancers at different locations in the body responded positively to larotrectinib, a novel treatment that targets a genetic mutation.
Researchers published the results of the phase 1/2 trial in the New England Journal of Medicine on February 22, 2018.
Source:
